Prosiectau (123)
Cardiff University Schools involved in this Project
Targeting cartilage regeneration in joint and intervertebral disc diseases (01.03.2015 - 28.02.2019)
- Caterson, Bruce
Targeting CD200 signalling to overcome cell carcinoma immune evasion (01.01.2014 - 31.07.2017)
- Clarke, Alan
Targeting common mechanisms of pathogenesis in diseases of sterol homeostasis associated with lysosome dysfunction development of novel and rapidly translatable clinical therapies (STEROLOSOM) (01.06.2012 - 31.05.2014)
- Lloyd-Evans, Emyr
Targeting ERK signalling to ameliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2 (01.11.2019 - 31.10.2025)
- Brambilla, Riccardo
Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2 (01.11.2019 - 31.10.2025)
- Brambilla, Riccardo
Targeting long-term responses to chemotherapy through a novel stem/immune-related vulnerability in triple negative breast cancer (23.03.2023 - 22.03.2026)
- Clarkson, Richard
Targeting the Wnt receptor frizzled-7 for the treatment of gastric cancer (01.09.2018 - 31.08.2021)
- Phesse, Toby
Targeting Wnt signaling to treat metastatic prostate cancer (01.09.2021 - 31.07.2025)
- Phesse, Toby
Target validation and lead identification in osteoarthritis (01.12.2011 - 30.11.2013)
- Blain, Emma
Target validation laboratories suite in the Medicine Discovery Institute (01.10.2019 - 31.10.2020)
- Atack, John